ARES TRADING S.A.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 52203
 
  
 
C07K PEPTIDES 22114
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 19135
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 10157
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 693
 
  
 
C07D HETEROCYCLIC COMPOUNDS 5157
 
  
 
1404 SCREEN DISPLAYS AND ICONS555
 
  
 
B65D CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 494
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 3237
 
  
 
C08F MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 2123

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0348,225 LIQUID PHARMACEUTICAL COMPOSITIONDec 17, 15Dec 07, 17[A61K]
2017/0196,974 LIQUID PHARMACEUTICAL COMPOSITIONMay 15, 15Jul 13, 17[A61K, C07K]
2017/0182,162 LIQUID PHARMACEUTICAL COMPOSITIONMay 15, 15Jun 29, 17[A61K, C07K]
2017/0145,068 NOVEL IFN BETA PROTEIN ANALOGSApr 01, 15May 25, 17[C07K]
2017/0020,960 LIQUID FORMULATIONS OF TUMOR NECROSIS FACTOR-BINDING PROTEINSSep 30, 16Jan 26, 17[A61J, A61K]
2016/0246,943 PATIENT CARE SYSTEM REPORTING ADHERENCE TO TREATMENT REGIMENOct 25, 14Aug 25, 16[G06F]
2015/0174,324 INJECTION DEVICEJun 11, 13Jun 25, 15[A61M]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9795714 FGF-18 formulation in alginate/collagen hydrogelsDec 23, 14Oct 24, 17[A61K, A61L, C07K]
9700595 Liquid formulation of a fusion protein comprising TNFR and Fc regionNov 28, 14Jul 11, 17[A61K, C07K]
9567577 Expression vector comprising a polynucleotide encoding a modified glutamine synthetase and a method for preparing a target protein employing the sameMar 05, 13Feb 14, 17[A61K, C12N, C07K]
D776270 Connection station for drug delivery devicesJul 18, 14Jan 10, 17[2401]
9534054 Monoclonal antibody directed against CXCR5Apr 30, 14Jan 03, 17[A61K, C07K]
9527853 Fused triazole derivatives as gamma secretase modulatorsJun 14, 13Dec 27, 16[A61K, C07D]
9512215 Liquid formulations of tumor necrosis factor-binding proteinsDec 15, 14Dec 06, 16[A61K, C07K]
9403835 Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulatorsNov 30, 12Aug 02, 16[A61K, C07D]
D757071 Display screen with graphical user interfaceApr 23, 14May 24, 16[1404]
D756391 Display screen with graphical user interfaceApr 23, 14May 17, 16[1404]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0211,057 Expression Vector Comprising a Polynucleotide Encoding a Modified Glutamine Synthetase and a Method for Preparing a Target Protein Employing the SameAbandonedJan 05, 17Jul 27, 17[A61K, C12N, C07K]
2016/0228,374 FREEZE-DRIED FORMULATIONS OF FGF-18AbandonedApr 26, 16Aug 11, 16[A61K]
2016/0051,671 COMBINATION OF BLyS INHIBITION AND ANTI-CD 20 AGENTS FOR TREATMENT OF AUTOIMMUNE DISEASEAbandonedJan 12, 15Feb 25, 16[A61K]
2015/0017,164 COMBINATION OF BLyS AND/OR APRIL INHIBITION AND IMMUNOSUPPRESSANTS FOR TREATMENT OF AUTOIMMUNE DISEASEAbandonedAug 18, 14Jan 15, 15[A61K]
2014/0328,869 METHODS FOR IMPROVING THE DESIGN, BIOAVAILABILITY, AND EFFICACY OF RANDOM SEQUENCE POLYMER COMPOSITIONS VIA SERUM PROTEIN-BASED DETECTION OF RANDOM SEQUENCE POLYMER COMPOSITIONSAbandonedMay 08, 14Nov 06, 14[G01N]
2014/0249,089 METHODS OF TREATING DISEASE WITH RANDOM COPOLYMERSAbandonedJan 31, 14Sep 04, 14[C07K]
8604175 Method for purifying FSH or a FSH mutantExpiredDec 06, 06Dec 10, 13[C07K]
2013/0172,391 PHARMACEUTICAL COMPOSITIONSAbandonedFeb 01, 13Jul 04, 13[A61K]
2013/0158,077 PHARMACEUTICAL COMPOSITIONSAbandonedOct 18, 12Jun 20, 13[A61K, A61P]
8329654 Use of IL-6/IL-6 chimera in Huntington's diseaseExpiredMar 04, 10Dec 11, 12[A61K]
2012/0282,296 METHODS FOR IMPROVING THE DESIGN, BIOAVAILABILITY, AND EFFICACY OF DIRECTED SEQUENCE POLYMER COMPOSITIONS VIA SERUM PROTEIN-BASED DETECTION OF DIRECTED SEQUENCE POLYMER COMPOSITIONSAbandonedNov 17, 10Nov 08, 12[A61K, A61P, C40B]
8277839 Oral pharmaceutical composition of anilinopyrimidine, preparation and use thereofExpiredJul 05, 07Oct 02, 12[A61K, A61P]
8222371 IG domain containing proteinsExpiredOct 28, 05Jul 17, 12[A61K, C07K]
8178083 Treatment of optic neuritisExpiredAug 30, 06May 15, 12[A61K]
8124748 Cell surface glycoproteinExpiredAug 11, 05Feb 28, 12[C07H, C12P, C12N]
8080419 Process for recycling solid supports for cultivation of anchorage-dependent cellsExpiredNov 26, 04Dec 20, 11[C12Q, C12P, C12N, C12M]
8008333 Single dose aromatase inhibitor for treating infertilityExpiredApr 17, 02Aug 30, 11[A61K]
7879320 Hydrogel interferon formulationsExpiredMay 13, 05Feb 01, 11[A61K, C07K]
7858082 Method of stabilizing proteinsExpiredMay 27, 05Dec 28, 10[A61K]
7846957 Aromatase inhibition to enhance assisted reproductionExpiredApr 17, 02Dec 07, 10[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.